S M Eschmann

Summary

Country: Germany

Publications

  1. ncbi request reprint [18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer]
    R Bares
    Klinischen Abteilung Nuklearmedizin der Radiologischen Universitätsklinik Tübingen, Röntgenweg 13 15, D 72 076 Tübingen, Deutschland
    Acta Med Austriaca 29:171-5. 2002
  2. ncbi request reprint 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
    Susanne Martina Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:463-71. 2007
  3. doi request reprint Correlative imaging of hypoxia and angiogenesis in oncology
    Karl Josef Langen
    Institute of Neuroscience and Biophysics Medicine, Research Center Julich, D 52425 Julich, Germany
    J Nucl Med 49:515-6. 2008
  4. doi request reprint Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study
    H Stergar
    Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
    Nuklearmedizin 49:129-37. 2010
  5. pmc Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
    Daniela Thorwarth
    Section for Biomedical Physics, Clinic for Radiation Oncology, University Hospital Tubingen, Germany
    BMC Cancer 5:152. 2005
  6. ncbi request reprint Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
    Susanne M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Roentgenweg 13, Germany
    Eur J Nucl Med Mol Imaging 29:760-7. 2002
  7. ncbi request reprint Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076 Tubingen, Germany
    Eur J Nucl Med Mol Imaging 33:263-9. 2006
  8. ncbi request reprint The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer
    Susanne M Eschmann
    Departments of Nuclear Medicine, University of Tuebingen, Otfried Müller Strasse 14, D 72076 Tuebingen, Germany
    Nucl Med Commun 25:909-15. 2004
  9. ncbi request reprint Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study
    S M Eschmann
    University of Tuebingen, Department of Nuclear Medicine, Germany
    Exp Clin Endocrinol Diabetes 114:222-6. 2006
  10. ncbi request reprint Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy
    Susanne Martina Eschmann
    Department of Nuclear Medicine, University of Tuebingen, D 72076 Tuebingen, Germany
    J Nucl Med 46:253-60. 2005

Collaborators

Detail Information

Publications35

  1. ncbi request reprint [18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer]
    R Bares
    Klinischen Abteilung Nuklearmedizin der Radiologischen Universitätsklinik Tübingen, Röntgenweg 13 15, D 72 076 Tübingen, Deutschland
    Acta Med Austriaca 29:171-5. 2002
    ..New applications of PET may include non-invasive evaluation of tissue proliferation or hypoxia to predict individual prognosis or treatment response...
  2. ncbi request reprint 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
    Susanne Martina Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:463-71. 2007
    ..The aim of this study was to evaluate FDG-PET for assessment of therapy response and for prediction of patient outcome after neo-adjuvant radio-chemotherapy (NARCT) of advanced non-small cell lung cancer (NSCLC)...
  3. doi request reprint Correlative imaging of hypoxia and angiogenesis in oncology
    Karl Josef Langen
    Institute of Neuroscience and Biophysics Medicine, Research Center Julich, D 52425 Julich, Germany
    J Nucl Med 49:515-6. 2008
  4. doi request reprint Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study
    H Stergar
    Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
    Nuklearmedizin 49:129-37. 2010
    ..to evaluate the image quality and 3.) to determine both, the quantity and the quality of artefacts in whole body FDG PET/CT scans...
  5. pmc Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
    Daniela Thorwarth
    Section for Biomedical Physics, Clinic for Radiation Oncology, University Hospital Tubingen, Germany
    BMC Cancer 5:152. 2005
    ..For a better understanding of tracer uptake and distribution, a kinetic model was developed to analyze dynamic Fmiso PET data...
  6. ncbi request reprint Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
    Susanne M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Roentgenweg 13, Germany
    Eur J Nucl Med Mol Imaging 29:760-7. 2002
    ..The applied technique might be particularly useful for quantitative dose-response studies in radioiodine treatment and further investigations of stunning phenomena...
  7. ncbi request reprint Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076 Tubingen, Germany
    Eur J Nucl Med Mol Imaging 33:263-9. 2006
    ..J Nucl Med 2000;41:85-92). On the basis of these observations, we studied the influence of FDG uptake on prognosis and occurrence of distant metastases in patients with advanced NSCLC...
  8. ncbi request reprint The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer
    Susanne M Eschmann
    Departments of Nuclear Medicine, University of Tuebingen, Otfried Müller Strasse 14, D 72076 Tuebingen, Germany
    Nucl Med Commun 25:909-15. 2004
    ....
  9. ncbi request reprint Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study
    S M Eschmann
    University of Tuebingen, Department of Nuclear Medicine, Germany
    Exp Clin Endocrinol Diabetes 114:222-6. 2006
    ..This study analyses prospectively the influence of discontinuing antithyroid drugs (ATD) immediately prior to treatment with radioiodine on the therapeutic outcome...
  10. ncbi request reprint Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy
    Susanne Martina Eschmann
    Department of Nuclear Medicine, University of Tuebingen, D 72076 Tuebingen, Germany
    J Nucl Med 46:253-60. 2005
    ..The PET tracer (18)F-fluoromisonidazole (FMISO) allows noninvasive assessment of tumor hypoxia. This study analyzed whether FMISO PET could predict tumor recurrence after radiotherapy...
  11. pmc Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:54-9. 2007
    ..In one group, FDG-PET was part of the pretherapeutic staging, whereas in the other group, no PET scans were performed...
  12. ncbi request reprint Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
    S M Eschmann
    University of Tuebingen, Department of Nuclear Medicine, Tuebingen, Germany
    Lung Cancer 55:165-71. 2007
    ..Aim of this study was to evaluate FDG-PET for monitoring treatment response during and after neoadjuvant radiochemotherapy (NARCT) in advanced NSCLC...
  13. ncbi request reprint FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy
    S M Eschmann
    Department of Nuclear Medicine, University Hospital Tubingen, Roentgenweg 13, Germany
    Eur J Nucl Med Mol Imaging 29:804-8. 2002
    ..FDG PET is the most accurate non-invasive diagnostic procedure for the staging of advanced NSCLC. Therefore use of FDG PET is highly recommended in order to select patients for neoadjuvant or other stage-dependent treatment modalities...
  14. ncbi request reprint Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
    S M Eschmann
    Department of Nuclear Medicine, Eberhard Karls Universitat Tubingen, Germany
    Nuklearmedizin 46:161-8; quiz N47-8. 2007
    ..Aim of this study was to compare the diagnostic accuracy of positron emission tomography and computed tomography with (11)C-Choline (Cho-PET/CT) and whole body magnetic resonance imaging (WB-MRI) for diagnostic work-up of prostate cancer...
  15. ncbi request reprint Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study
    H Stergar
    Department of Nuclear Medicine, University Hospital Essen, Hufelandstr 55, 45122 Essen, Germany
    Nuklearmedizin 46:57-64. 2007
    ..To evaluate the influence of the introduction of combined PET/CT scanners into clinical routine. This investigation addresses the quantitative changes between PET/CT and stand alone PET...
  16. ncbi request reprint On biologically conformal boost dose optimization
    M Alber
    Department of Medical Physics University of Tübingen, Tubingen, Germany
    Phys Med Biol 48:N31-5. 2003
    ....
  17. ncbi request reprint Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging
    A C Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University Tuebingen, Hoppe Seyler Strasse 3, 72076 Tuebingen, Germany
    Br J Radiol 80:437-45. 2007
    ..Diagnostic multiphase CT as part of the combined PET/CT protocol has the potential to provide considerable additional value in specific clinical conditions with resultant change of management in a substantial proportion of patients...
  18. ncbi request reprint A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia
    Daniela Thorwarth
    Section for Biomedical Physics, University Hospital for Radiation Oncology, Hoppe Seyler Str 3, 72076 Tubingen, Germany
    Phys Med Biol 50:2209-24. 2005
    ..The derived independent measures for perfusion and hypoxia may provide a basis for individually adapted treatment planning...
  19. pmc [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
    Barbara Gehler
    Department of Radiation Oncology, LMU Munchen, Marchioninistr, 15, 81377 Munchen, Germany
    Radiat Oncol 4:56. 2009
    ....
  20. ncbi request reprint Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CT
    Matthias P Lichy
    Department of Diagnostic Radiology, Medical Solutions, Erlangen, Germany
    Invest Radiol 42:605-13. 2007
    ..To evaluate the clinical potential of diffusion-weighted-imaging (DWI) with apparent diffusion coefficient (ADC)-mapping for tumor detection...
  21. ncbi request reprint Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma
    Christina Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University Tuebingen, Hoppe Seyler Strasse 3, 72076 Tuebingen, Germany
    Eur J Cancer 43:557-64. 2007
    ..In 41 patients (64%) whole-body imaging caused changes of treatment. Whole-body staging of patients with advanced melanoma is most accurate by combining wbPET/CT and organ-specific wbMRI including a brain, liver and bone marrow protocol...
  22. ncbi request reprint Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspects
    Klaus Brechtel
    Department of Diagnostic Radiology, University of Tuebingen, Tuebingen, Germany
    Nucl Med Commun 28:141-7. 2007
    ..To evaluate the use of a fixation device in whole-body postiron emission tomography/computed tomography (PET/CT)...
  23. ncbi request reprint Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer
    Anna C Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:36-44. 2007
    ..To evaluate low dose non-enhanced CT and standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning of non-small cell lung cancer (NSCLC)...
  24. ncbi request reprint Combined transmission and emission tomography in a vastus intermedius muscle stress syndrome
    M Horger
    Department of Diagnostic Radiology, Eberhard Karls Universitat, Hoppe Seyler Strasse 3, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 30:636. 2003
  25. ncbi request reprint Dual-phase multidetector thin-section CT in detecting duodenal gastrinoma
    A C Pfannenberg
    Department of Diagnostic Radiology, University of Tuebingen, Hoppe Seyler Str 3, 72076 Tuebingen, Germany
    Abdom Imaging 30:543-7. 2005
    ..The case illustrates that appropriate computed tomographic technique and scanning protocol are crucial for success in localizing extrapancreatic gastrinoma...
  26. doi request reprint Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol
    Thomas Hehr
    Department of Radiation Oncology, University Tübingen, Tubingen, Germany
    Int J Radiat Oncol Biol Phys 76:1376-81. 2010
    ....
  27. ncbi request reprint Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels
    Matthias P Lichy
    Department of Urology, Comprehensive Cancer Center Tübingen, Eberhard Karls Universitat Tubingen, Tubingen, Germany
    Urology 69:1208.e5-8. 2007
    ..Magnetic resonance imaging-guided prostate biopsy was successfully performed. All specimens taken from the lesion showed a Gleason 5 tubular adenocarcinoma with low proliferative activity...
  28. ncbi request reprint Evaluation of combined transmission and emission tomography for classification of skeletal lesions
    Marius Horger
    Department of Diagnostic Radiology, Eberhard Karls University, Hoppe Seyler Strasse 3, Tuebingen 72076, Germany
    AJR Am J Roentgenol 183:655-61. 2004
    ..This study assessed the benefit of transmission emission tomography (TET) for classification of skeletal lesions in patients with known malignant disease...
  29. ncbi request reprint The value of SPET/CT in chronic osteomyelitis
    Marius Horger
    Department of Diagnostic Radiology, Eberhard Karls Universitat, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 30:1665-73. 2003
    ..This technique may gain clinical relevance in the selection of patients for surgical therapy...
  30. ncbi request reprint Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography
    Marius Horger
    Department of Diagnostic Radiology, Eberhard Karls Universitat, Hoppe Seyler Strasse 3, 72076 Tubingen, Germany
    Eur J Nucl Med Mol Imaging 30:316-9. 2003
    ..Diagnostic relevance was highest for intrahepatic, intrapulmonary or pleural splenic implants. It is concluded that TET allows exact localisation of heterotopic splenic tissue in patients with suspected splenosis...
  31. ncbi request reprint Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer
    Susanne Martina Eschmann
    Department of Nuclear Medicine, Marienhospital Stuttgart, Germany
    Radiother Oncol 83:406-10. 2007
    ..PET with (18)F-Misonidazole (FMISO-PET) is a non-invasive method for measuring tumor hypoxia. We analysed changes of FMISO-uptake during radiotherapy and their impact on patient outcome...
  32. ncbi request reprint [18F]FLT PET for diagnosis and staging of thoracic tumours
    Helmut Dittmann
    Department of Nuclear Medicine, Eberhard Karls University Tubingen, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 30:1407-12. 2003
    ..In the liver and the bone marrow, high physiological FLT uptake hampers detection of metastases. On the other hand, FLT may be favourable for imaging of brain metastases owing to the low physiological uptake...
  33. ncbi request reprint Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms
    Anna Christina Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University Tubingen, Germany
    Eur J Nucl Med Mol Imaging 30:835-43. 2003
    ..Anatomical-functional image fusion allows for improved localisation and characterisation of NET with resultant alteration of the treatment approach in a substantial proportion of patients...
  34. ncbi request reprint Added value of SPECT/CT in patients suspected of having bone infection: preliminary results
    Marius Horger
    Department of Diagnostic Radiology, Eberhard Karls University, Hoppe Seyler Strasse 3, 72076, Tuebingen, Germany
    Arch Orthop Trauma Surg 127:211-21. 2007
    ..Subsequently, the diagnostic performance of SPECT/CT was compared to visual fusion of SPECT with data of additional CT, X-ray, or MRI studies (SPECT + CT/X-ray/MRI)...
  35. ncbi request reprint First experiences of radiation treatment planning with PET/CT
    Frank Paulsen
    Clinic for Radiation Oncology, University of Tuebingen, Germany
    Strahlenther Onkol 182:369-75. 2006
    ..Its value for modern radiation treatment planning is under investigation...